Diversified developed-market income — semi-annual, real, compounding. A 3.09% trailing yield from a multifactor portfolio of developed-market stocks outside North America, weighted toward smaller, cheaper, more profitable companies at a 0.39% net expense ratio, with $1.36 of distributions over the trailing twelve months ($0.5895 in December 2025 and $0.7711 in June 2026) at the $44.02 close on October 23, 2026. The payout is funded by the holdings’ dividends, not leverage or options, and the price is up about 8% over the past year, so distributions have been paid on top of growth rather than carved out of principal. Budget on the trailing twelve months, not on any single payment — the semi-annual amounts swing from about $0.59 to $0.77 because the underlying payers cluster their dividends.
Key risk: Semi-annual lumpiness and currency exposure — the income arrives twice a year in uneven amounts, and a developed-ex-U.S. portfolio moves with foreign currencies and overseas markets as much as with the dividends themselves; the 0.39% fee takes about an eighth of the trailing yield before a dollar reaches the holder.
Changes if: Trailing-12-month distributions fall for two consecutive semi-annual periods, or the expense ratio rises materially. Semi-annual lumpiness alone is not a tripwire — the trailing total is.
- ✓Yield check: 3.09% trailing — $1.36 of distributions over the trailing 12 months ($0.5895 in December 2025 plus $0.7711 in June 2026) at the $44.02 close on October 23, 2026. That sits in the moderate-yield band for a developed international fund — income with growth still attached.
- !Expense check: 0.39% net a year (0.43% gross) is more than six times SCHD’s 0.06%. Multifactor screening across developed markets is what the extra fee buys — judge whether it is worth it, and note it consumes roughly an eighth of the trailing yield.
- !Distribution-pattern check: Semi-annual amounts swing from $0.59 to $0.77 because the underlying payers cluster their dividends — the income is real, but a single payment says almost nothing about the run rate; the $1.36 trailing total is the figure to watch.
- ✓Trap check — distribution vs. total return: Passed — the price is up about 8% over the past year despite roughly 3% annual distributions: the distributions were paid on top of growth, not carved out of principal, and no return-of-capital funding was indicated.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.